Midkine and pleiotrophin expression in normal and malignant breast tissue

Background. Some growth factors may promote tumor growth by affecting tumor angiogenesis. The angiogenic growth factor, pleiotrophin, was demonstrated previously in human breast carcinoma tissues; however, the pattern of pleiotrophin expression in normal breast tissues has not been established.

[1]  R. Garver,et al.  Reciprocal expression of pleiotrophin and midkine in normal versus malignant lung tissues. , 1993, American journal of respiratory cell and molecular biology.

[2]  A. Nakagawara,et al.  A new family of heparin-binding growth/differentiation factors: increased midkine expression in Wilms' tumor and other human carcinomas. , 1993, Cancer research.

[3]  A. Wellstein,et al.  Pleiotrophin stimulates fibroblasts and endothelial and epithelial cells and is expressed in human cancer. , 1992, The Journal of biological chemistry.

[4]  F Pozza,et al.  Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. , 1992, Journal of the National Cancer Institute.

[5]  H. Donis-Keller,et al.  Cloning, nucleotide sequence, and chromosome localization of the human pleiotrophin gene. , 1992, Biochemistry.

[6]  T. Muramatsu,et al.  A new family of heparin binding growth/differentiation factors: differential expression of the midkine (MK) and HB-GAM genes during mouse development. , 1992, Journal of biochemistry.

[7]  R. Lupu,et al.  Purification and characterization of a novel growth factor from human breast cancer cells. , 1992, Biochemistry.

[8]  T. Muramatsu,et al.  Genomic structure of human midkine (MK), a retinoic acid-responsive growth/differentiation factor. , 1992, Journal of biochemistry.

[9]  A. Wellstein,et al.  A heparin-binding growth factor secreted from breast cancer cells homologous to a developmentally regulated cytokine. , 1992, The Journal of biological chemistry.

[10]  J. Courty,et al.  Mitogenic properties of a new endothelial cell growth factor related to pleiotrophin. , 1991, Biochemical and biophysical research communications.

[11]  T. Muramatsu,et al.  Purification of recombinant midkine and examination of its biological activities: functional comparison of new heparin binding factors. , 1991, Biochemical and biophysical research communications.

[12]  T. Muramatsu,et al.  A new family of heparin-binding factors: strong conservation of midkine (MK) sequences between the human and the mouse. , 1991, Biochemical and biophysical research communications.

[13]  J. Folkman,et al.  Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. , 1991, The New England journal of medicine.

[14]  M. Watson,et al.  Cloning and expression of a developmentally regulated protein that induces mitogenic and neurite outgrowth activity. , 1990, Science.

[15]  R. Kikuno,et al.  Isolation of mouse and human cDNA clones encoding a protein expressed specifically in osteoblasts and brain tissues. , 1990, Biochemical and biophysical research communications.

[16]  H. Rauvala,et al.  Molecular cloning of the 18-kDa growth-associated protein of developing brain. , 1990, The Journal of biological chemistry.

[17]  G. Merlo,et al.  Transforming growth factor-alpha messenger RNA localization in the developing adult rat and human mammary gland by in situ hybridization. , 1990, Developmental biology.

[18]  R. Huang,et al.  A retinoic acid responsive gene MK found in the teratocarcinoma system is expressed in spatially and temporally controlled manner during mouse embryogenesis , 1990, The Journal of cell biology.

[19]  M. Korc,et al.  Differential regulation of expression of three transforming growth factor beta species in human breast cancer cell lines by estradiol. , 1990, Cancer research.

[20]  T. Deuel,et al.  A novel 17 kD heparin-binding growth factor (HBGF-8) in bovine uterus: purification and N-terminal amino acid sequence. , 1989, Biochemical and biophysical research communications.

[21]  H. Rauvala.  An 18‐kd heparin‐binding protein of developing brain that is distinct from fibroblast growth factors. , 1989, The EMBO journal.

[22]  J. Foekens,et al.  Insulin‐like growth factor‐1 receptors and insulin‐like growth factor‐1‐like activity in human primary breast cancer , 1989, Cancer.

[23]  A. Howell,et al.  Epidermal and transforming growth factor alpha in patients with breast tumours. , 1989, British Journal of Cancer.

[24]  D. Yee,et al.  Insulin-like growth factor II mRNA expression in human breast cancer. , 1988, Cancer research.

[25]  T. Powles,et al.  Growth factor expression in normal, benign, and malignant breast tissue , 1988, British medical journal.

[26]  S. Bates,et al.  Expression of transforming growth factor alpha and its messenger ribonucleic acid in human breast cancer: its regulation by estrogen and its possible functional significance. , 1988, Molecular endocrinology.

[27]  T. Muramatsu,et al.  cDNA cloning and sequencing of a new gene intensely expressed in early differentiation stages of embryonal carcinoma cells and in mid-gestation period of mouse embryogenesis. , 1988, Biochemical and biophysical research communications.

[28]  R. Derynck,et al.  Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells , 1987, Cell.

[29]  R. Henderson,et al.  Biologic properties of cell lines derived from canine mammary carcinomas. , 1986, Journal of the National Cancer Institute.

[30]  S. Bates,et al.  Characterization of estrogen responsive transforming activity in human breast cancer cell lines. , 1986, Cancer research.

[31]  R. Dickson,et al.  Breast cancer: influence of endocrine hormones, growth factors and genetic alterations. , 1993, Advances in experimental medicine and biology.

[32]  S. Bates,et al.  Expression of the transforming growth factor-alpha/epidermal growth factor receptor pathway in normal human breast epithelial cells. , 1990, Endocrinology.

[33]  R. Champlin.  Role of bone marrow transplantation as treatment for victims of nuclear accidents. , 1990, Cancer treatment and research.